Figure 1.
![Gut microbiota alpha diversity of patients with PV, of the different PV treatment groups, and of HCs. (A) Gut microbiota alpha diversity (median Inverse Simpson Index [InvSimpson]) of HCs and patients with PV. Alpha diversity differed significantly between patients with PV (median InvSimpson, 20.2) and HCs (median InvSimpson, 26.3) (P = .016). (B) Alpha diversity (InvSimpson) of HCs, COMBI, HU, IFN-α2, and NT group. After adjusting for multiple testing, no significant difference was found.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/13/10.1182_bloodadvances.2022008555/1/blooda_adv-2022-008555-gr1.jpeg?Expires=1736045979&Signature=i1ztzdg0pAeDURO~Zqr4NXlWZRQ29qUlUYJ-tGAOUT0ClrEPULOF4hKZou--an~QoBVWa7EpcN2tFFRLiOw0V9voUeR4IN54fwpk4MXQsQ5zTloFQkYJvUBnEa1X8iYNIp5JcYycgRmmcd8eQL4fwT6VirC1CkiV4R6XHJ1I3xwp7BDyiqbNL0JqTXw7l25EkfgqU7RqnM~m~RjU17yflxDtzFs31uwjZsil7bFWrJkzUwjGXphAY~PN4lQc2X7IWkjXDVHyYbBtp4EqrY5id22FD0W23fkYbw19fsb-ftG0VqQDfJqjnyaikN~ErEn0rvDqClKCw7xm-mIg80dafg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Gut microbiota alpha diversity of patients with PV, of the different PV treatment groups, and of HCs. (A) Gut microbiota alpha diversity (median Inverse Simpson Index [InvSimpson]) of HCs and patients with PV. Alpha diversity differed significantly between patients with PV (median InvSimpson, 20.2) and HCs (median InvSimpson, 26.3) (P = .016). (B) Alpha diversity (InvSimpson) of HCs, COMBI, HU, IFN-α2, and NT group. After adjusting for multiple testing, no significant difference was found.
